| Cyclic administration of pamidronate in children with severe osteogenesis imperfecta FH Glorieux, NJ Bishop, H Plotkin, G Chabot, G Lanoue, R Travers New England Journal of Medicine 339 (14), 947-952, 1998 | 1205 | 1998 |
| Osteogenesis imperfecta FH Glorieux, D Rowe Pediatric bone, 511-539, 2012 | 359 | 2012 |
| Normative data for iliac bone histomorphometry in growing children FH Glorieux, R Travers, A Taylor, JR Bowen, F Rauch, M Norman, ... Bone 26 (2), 103-109, 2000 | 356 | 2000 |
| Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1, 25-dihydroxyvitamin D and not to the absence of 24, 25 … R St-Arnaud, A Arabian, R Travers, F Barletta, M Raval-Pandya, K Chapin, ... Endocrinology 141 (7), 2658-2666, 2000 | 352 | 2000 |
| The 25‐hydroxyvitamin D 1‐alpha‐hydroxylase gene maps to the pseudovitamin D‐deficiency rickets (PDDR) disease locus R St‐Arnaud, S Messerlian, JM Moir, JL Omdahl, FH Glorieux Journal of Bone and Mineral Research 12 (10), 1552-1559, 1997 | 346 | 1997 |
| Structural and cellular changes during bone growth in healthy children AM Parfitt, R Travers, F Rauch, FH Glorieux Bone 27 (4), 487-494, 2000 | 336 | 2000 |
| Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate CFJ Munns, F Rauch, L Zeitlin, F Fassier, FH Glorieux Journal of Bone and Mineral Research 19 (11), 1779-1786, 2004 | 316 | 2004 |
| Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets FH Glorieux, PJ Marie, JM Pettifor, EE Delvin New England Journal of Medicine 303 (18), 1023-1031, 1980 | 311 | 1980 |
| Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial EA Imel, FH Glorieux, MP Whyte, CF Munns, LM Ward, O Nilsson, ... The Lancet 393 (10189), 2416-2427, 2019 | 291 | 2019 |
| Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis EE Delvin, BL Salle, FH Glorieux, P Adeleine, LS David The Journal of pediatrics 109 (2), 328-334, 1986 | 280 | 1986 |
| Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw AA Khan, GKB Sandor, E Dore, AD Morrison, M Alsahli, F Amin, E Peters, ... The Journal of rheumatology 35 (7), 1391-1397, 2008 | 276 | 2008 |
| Temporal and spatial expression of bone morphogenetic protein-2,-4, and-7 during distraction osteogenesis in rabbits F Rauch, D Lauzier, S Croteau, R Travers, FH Glorieux, R Hamdy Bone 26 (6), 611-617, 2000 | 263 | 2000 |
| Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone H Plotkin, F Rauch, L Zeitlin, C Munns, R Travers, FH Glorieux The Journal of Clinical Endocrinology & Metabolism 88 (10), 4569-4575, 2003 | 251 | 2003 |
| Bisphosphonate associated osteonecrosis of the jaw AA Khan, GKB Sandor, E Dore, AD Morrison, M Alsahli, F Amin, E Peters, ... The Journal of rheumatology 36 (3), 478-490, 2009 | 244 | 2009 |
| Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study LM Ward, F Rauch, MP Whyte, J D'astous, PE Gates, D Grogan, EL Lester, ... The Journal of Clinical Endocrinology & Metabolism 96 (2), 355-364, 2011 | 239 | 2011 |
| Modern approach to children with osteogenesis imperfecta L Zeitlin, F Fassier, FH Glorieux Journal of Pediatric Orthopaedics B 12 (2), 77-87, 2003 | 232 | 2003 |
| Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV L Zeitlin, F Rauch, H Plotkin, FH Glorieux Pediatrics 111 (5), 1030-1036, 2003 | 229 | 2003 |
| Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy F Rauch, H Plotkin, L Zeitlin, FH Glorieux Journal of Bone and Mineral Research 18 (4), 610-614, 2003 | 229 | 2003 |
| Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia FH Glorieux, CR Scriver, TM Reade, H Goldman, A Roseborough New England Journal of Medicine 287 (10), 481-487, 1972 | 226 | 1972 |
| Mutations in WNT1 are a cause of osteogenesis imperfecta S Fahiminiya, J Majewski, J Mort, P Moffatt, FH Glorieux, F Rauch Journal of medical genetics 50 (5), 345-348, 2013 | 219 | 2013 |
